age-dependent decline of the anti-tumour efficacy of local il-2 immunotherapy and chemoimmunotherapy utilizing human recombinant interleukin 2 and cyclophosphamide was investigated in b10 mice bearing syngeneic mc-induced sarcoma .
C0086418
human
C0021756
recombinant interleukin 2